You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 10,064,938


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,064,938
Title:Localized immunosuppression of allografts for peripheral nerve repair
Abstract: Embodiments described herein relate to restorative solutions for segmental peripheral nerve (PN) defects using allografted PNs for stimulating PN repair. More specifically, embodiments described herein provide for localized immunosuppression (LIS) surrounding PN allografts as an alternative to systemically suppressing a patient\'s entire immune system. Methods include localized release of immunosuppressive (ISV) agents are contemplated in one embodiment. Methods also include localized application of immunosuppressive (ISV) regulatory T-cells (Tregs) in other embodiments. Hydrogel carrier materials for delivery of ISV agents and are also described herein.
Inventor(s): Bushman; Jared (Laramie, WY)
Assignee: UNIVERSITY OF WYOMING (Laramie, WY)
Application Number:15/457,359
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,064,938

Introduction

Understanding the claims and patent landscape of a specific patent is crucial for businesses, inventors, and investors. This analysis will delve into the details of United States Patent 10,064,938, exploring its claims, the patent application process, and the broader patent landscape.

Patent Overview

United States Patent 10,064,938 is a granted patent that has undergone a rigorous examination process. Here, we will examine the key components of this patent.

Patent Claims

The claims of a patent are the most critical part, as they define the scope of the invention and its legal protection. Patent claims can be divided into independent and dependent claims, each serving a distinct purpose. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[2].

Claim Structure and Analysis

To analyze the claims of US Patent 10,064,938, one would typically use tools like the Patent Matrix software, which automates the import, parsing, and hierarchical arrangement of claims. This helps in compressing and expanding claims to focus on the independent claims first, making the review process more efficient[2].

Patent Application Process

The journey of a patent from application to grant involves several key steps.

Filing and Examination

When a patent application is submitted to the USPTO, it undergoes a thorough examination. The examiner reviews the application in light of prior art, which includes previously published patents and scientific literature. The examiner must determine whether the claims are novel, non-obvious, and useful[4].

Office Actions and Rejections

During the examination process, the patent applicant may receive office actions, including non-final rejections. These rejections are based on the examiner's interpretation of the prior art and the patentability of the claims. The applicant can respond by narrowing or limiting the scope of the claims to overcome the examiner's objections[4].

File Wrappers and Prosecution History

File wrappers, or prosecution histories, contain detailed records of the interactions between the patent applicant and the patent office.

Importance of File Wrappers

File wrappers provide essential context and insight into the patent application process. They include arguments made between the applicant and the examiner, prior art references, and administrative details. Analyzing file wrappers is crucial for understanding the legal status and technical features of the invention[4].

Example Analysis

For instance, if a patent application was rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) due to anticipation by prior art, the file wrapper would contain the examiner's arguments and the applicant's responses. This information can be vital for competitive intelligence and understanding the patent landscape[4].

Patent Landscape Analysis

Analyzing the patent landscape involves looking at the broader context of related patents and technological trends.

Technology and Market Trends

Patent landscape analysis helps in identifying who is innovating, what technologies are being developed, when these innovations are happening, and where they are being filed. This information is invaluable for R&D, corporate development, marketing, and investment analysts[4].

Global Patenting Trends

Global patenting trends can be analyzed based on time, technology, and country. For example, using the International Patent Classification (IPC) and the World Intellectual Property Organization (WIPO) technology categories, one can track the evolution of technologies over time and across different countries[1].

Competitive Intelligence

Patent information is a powerful tool for competitive intelligence.

Who, What, When, Where, and How

By analyzing patents, businesses can gain insights into their competitors' R&D activities, product development, and market strategies. This includes understanding the geographical distribution of inventors and the ownership rights of patents[1][4].

Example: US-JP Collaborative Search Pilot Program

Initiatives like the US-JP Collaborative Search Pilot Program between the USPTO and the Japan Patent Office (JPO) facilitate more efficient and accurate patent examinations, which can impact the competitive landscape by speeding up the process of bringing innovations to market[5].

Legal Considerations and Challenges

Patent law is complex, and there are several legal considerations and challenges that can arise.

Obviousness and Prior Art

Patents must overcome the hurdles of obviousness and prior art. The examiner's determination of whether the claims are novel and non-obvious is critical. Cases like the Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd. have shaped the legal precedent on claims interpretation and the doctrine of equivalents[2][4].

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

Issues related to Patent Term Adjustment (PTA) and Patent Term Extension (PTE) can significantly impact the validity and duration of a patent. The case of In re Cellect highlights the complexities and legal challenges associated with these adjustments[3].

Key Takeaways

  • Claims Analysis: The claims of a patent define its legal scope and are crucial for understanding the invention's protection.
  • Patent Application Process: The examination process involves rigorous review against prior art, with potential office actions and rejections.
  • File Wrappers: These contain valuable information on the patent application process and are essential for competitive intelligence.
  • Patent Landscape: Analyzing related patents and technological trends provides insights into market and R&D activities.
  • Legal Considerations: Understanding obviousness, prior art, PTA, and PTE is vital for navigating patent law challenges.

FAQs

What is the significance of patent claims in a patent application?

Patent claims are the most critical part of a patent application as they define the scope of the invention and its legal protection.

How do file wrappers contribute to patent analysis?

File wrappers provide detailed records of the interactions between the patent applicant and the patent office, offering insights into the patentability and legal status of the invention.

What is the role of prior art in the patent examination process?

Prior art includes previously published patents and scientific literature that the examiner reviews to determine whether the claims are novel, non-obvious, and useful.

How can businesses use patent landscape analysis for competitive intelligence?

By analyzing patents, businesses can gain insights into their competitors' R&D activities, product development, and market strategies, helping them make informed decisions.

What are the implications of Patent Term Adjustment (PTA) and Patent Term Extension (PTE) on a patent?

PTA and PTE can affect the duration and validity of a patent, with legal challenges arising from their application, as seen in cases like In re Cellect.

Sources

  1. National Science Foundation. Invention, Knowledge Transfer, and Innovation. Science and Engineering Indicators 2024: Technical Documentation.
  2. Google Patents. US20110138338A1 - Patent Claims Analysis System and Method.
  3. United States Court of Appeals for the Federal Circuit. In re Cellect.
  4. IP Checkups. Patent file wrappers as a tool for competitive intelligence.
  5. Japan Patent Office. US-JP Collaborative Search Pilot Program.

More… ↓

⤷  Subscribe

Details for Patent 10,064,938

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Pharmacia & Upjohn Company Llc ATGAM lymphocyte immune globulin, anti-thymocyte globulin (equine) Injection 103676 December 04, 1996 10,064,938 2036-03-11
Novartis Pharmaceuticals Corporation SIMULECT basiliximab For Injection 103764 May 12, 1998 10,064,938 2036-03-11
Novartis Pharmaceuticals Corporation SIMULECT basiliximab For Injection 103764 January 02, 2003 10,064,938 2036-03-11
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 10,064,938 2036-03-11
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 10,064,938 2036-03-11
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 October 12, 2004 10,064,938 2036-03-11
Biogen Inc. ZINBRYTA daclizumab Injection 761029 May 27, 2016 10,064,938 2036-03-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.